We are live on
!
Find out more
TAS
TIFF Advisory Services Portfolio holdings
AUM
$444M
1-Year Est. Return
24.8%
This Fund
S&P 500
This Quarter
Est. Return
+4.74%
1 Year Est. Return
+24.8%
3 Year Est. Return
+80.08%
5 Year Est. Return
+70.73%
10 Year Est. Return
+269.48%
AUM
$186M
AUM Growth
-$28.9M
(-13%)
Cap. Flow
-$38.6M
Cap. Flow
% of AUM
-20.72%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
3
Increased
2
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$3.25M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$3.19M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$3.15M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$1.12M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1,000K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$37.8M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$12.2M |
| 3 |
CytomX Therapeutics
CTMX
|
+$320K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 0% |
Similar funds
FWSM
TC
ACA
WCP
SGCM
AFA
CMP
CP
TIFF Advisory Services's Q3 2018 Portfolio in Review
As of Q3 2018, TIFF Advisory Services held 8 positions worth $186M, down 13% from $215M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
TIFF Advisory Services withdrew a net $38.6M in Q3 2018, closing 1 position and reducing 2 holdings. Its most notable exit was CytomX Therapeutics, an estimated $320K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 0% of assets, down from 0.15% a quarter earlier.
Against the trend, TIFF Advisory Services opened a new position in iShares Russell 2000 ETF worth $3.25M.
- TIFF Advisory Services's largest Q3 2018 buy was iShares Russell 2000 ETF: 19,261 shares worth $3.25M.
- TIFF Advisory Services added most to State Street Financial Select Sector SPDR ETF in Q3 2018, an estimated $3.19M increase.
- TIFF Advisory Services's biggest Q3 2018 reduction was Vanguard S&P 500 ETF, cutting an estimated $37.8M.
- TIFF Advisory Services fully exited CytomX Therapeutics in Q3 2018, selling an estimated $320K.
- TIFF Advisory Services's ten largest holdings make up 100% of its $186M portfolio in Q3 2018.
- TIFF Advisory Services opened 3 new positions and closed 1 in Q3 2018.
- TIFF Advisory Services's portfolio value fell 13% quarter-over-quarter to $186M.
Based on TIFF Advisory Services's 13F filing for Q3 2018, filed 9 Nov 2018.